Project Grant HT94252510436
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68105, USA
Similar Awards
The federal Project Grant award of $846,220 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to the Board of Regents of the University of Nebraska Medical Center (UNMC) on March 1, 2024. The award supports a 3-year research project titled "The Role of Astrocyte in Sleep Impairments in ASD" that aims to investigate the link between astrocyte function and sleep disturbances in individuals with autism spectrum...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
The Board of Regents of the University of Nebraska received a $300,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant funds research on "SOMATIC MUTATIONS IN NON-IG LOCI IN AUTOREACTIVE B CELLS AS DRIVERS OF LUPUS PATHOGENESIS AND DISEASE HETEROGENEITY" being conducted at the University of Nebraska Medical Center in Omaha, Nebraska from July 1, 2023 through June 30, 2025. The Military...
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
This $1,480,186 Project Grant award from the Defense Health Agency supports research by Northeast Ohio Medical University (Neomed) to model cognitive dysfunction in Parkinson's disease and the impact of exercise. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research, including solutions for the battlefield. As the sole awardee, Neomed...
The U.S. Department of Defense's Defense Health Agency awarded a $393,416 Project Grant to the Board of Regents of the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from September 1, 2024 to August 31, 2026, will support UNMC's research on the "Influence of Ocular Blast Injury on Retinal Output Synapses in the Brain". This project aims to advance the understanding of the...
This Project Grant award of $183,220.00 was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) Division. The award will fund research to target the CCL17/CCR4 axis in order to eradicate lung cancer brain metastasis. The research will be conducted at UNMC in Omaha, Nebraska and is scheduled to run from February...
The Defense Health Agency awarded a $386,250 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting the validation and inhibition of RHNO1 function in ovarian cancer. The two-year award beginning July 1, 2023 will fund preclinical research efforts to investigate medical solutions for ovarian cancer at the molecular level. As the parent organization, the Board of Regents of the University...